Delays in AF ablation cost lives

Journal of Cardiovascular ElectrophysiologyVolume 34, Issue 4 p. 1092-1093 LETTER TO THE EDITOR Delays in AF ablation cost lives Lisa W. M. Leung MBChB (Hons), MRCP, Corresponding Author Lisa W. M. Leung MBChB (Hons), MRCP [email protected] orcid.org/0000-0001-7485-6440 St George's Hospital NHS Foundation Trust, London, UK Correspondence Lisa W. M. Leung, MBChB (Hons), MRCP, St George's Hospital NHS Foundation Trust, London, UK. Email: [email protected]Search for more papers by this authorPavandeep Toor MBBS, Pavandeep Toor MBBS St George's Hospital NHS Foundation Trust, London, UKSearch for more papers by this authorZaki Akhtar MBBS, MRCP, Zaki Akhtar MBBS, MRCP St George's Hospital NHS Foundation Trust, London, UKSearch for more papers by this authorMark M. Gallagher MD, Mark M. Gallagher MD orcid.org/0000-0002-6333-6420 St George's Hospital NHS Foundation Trust, London, UKSearch for more papers by this author Lisa W. M. Leung MBChB (Hons), MRCP, Corresponding Author Lisa W. M. Leung MBChB (Hons), MRCP [email protected] orcid.org/0000-0001-7485-6440 St George's Hospital NHS Foundation Trust, London, UK Correspondence Lisa W. M. Leung, MBChB (Hons), MRCP, St George's Hospital NHS Foundation Trust, London, UK. Email: [email protected]Search for more papers by this authorPavandeep Toor MBBS, Pavandeep Toor MBBS St George's Hospital NHS Foundation Trust, London, UKSearch for more papers by this authorZaki Akhtar MBBS, MRCP, Zaki Akhtar MBBS, MRCP St George's Hospital NHS Foundation Trust, London, UKSearch for more papers by this authorMark M. Gallagher MD, Mark M. Gallagher MD orcid.org/0000-0002-6333-6420 St George's Hospital NHS Foundation Trust, London, UKSearch for more papers by this author First published: 02 March 2023 https://doi.org/10.1111/jce.15876 Disclosure: Dr Leung previously received research funding support from Attune Medical (Chicago, IL). Dr Gallagher has received research funding from Attune Medical and has acted as a consultant and a paid speaker for Boston Scientific and Cook Medical. Other authors: No disclosures. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1Sessions AJ, May HT, Crandall BG, et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart disease. J Cardiovasc Electrophysiol. Published online January 14, 2023. doi:10.1111/jce.15810 2Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019; 321(13): 1261- 1274. doi:10.1001/jama.2019.0693 3Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018; 378(5): 417- 427. doi:10.1056/NEJMoa1707855 4Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020; 383: 1305- 1316. doi:10.1056/NEJMoa2019422 5Noseworthy PA, Gersh BJ, Kent DM, et al. Atrial fibrillation ablation in practice: assessing CABANA generalizability. Eur Heart J. 2019; 40(16): 1257- 1264. doi:10.1093/eurheartj/ehz085 6Wazni OM, Dandamudi G, Sood N, et al. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021; 384(4): 316- 324. doi:10.1056/NEJMoa2029554 7Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021; 384(4): 305- 315. doi:10.1056/NEJMoa2029980 8Kuniss M, Pavlovic N, Velagic V, et al. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. EP Europace. 2021; 23: 1033- 1041. doi:10.1093/europace/euab029 9Andrade JG, Deyell MW, Macle L, et al. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2023; 388: 105- 116. doi:10.1056/NEJMoa2212540 10Leung LWM, Akhtar Z, Seshasai SRK, Gallagher MM. First-line management of paroxysmal atrial fibrillation: is it time for a ‘pill in the bin’ approach? A discussion on the STOPAF First, EARLYAF, Cryo-FIRST, and EAST-AF NET 4 clinical trials. EP Europace. 2022; 24: 533- 537. doi:10.1093/europace/euab259 11Leung LWM, Imhoff RJ, Marshall HJ, et al. Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom. J Cardiovasc Electrophysiol 2022; 33: 164- 175. doi:10.1111/jce.15317 Volume34, Issue4April 2023Pages 1092-1093 ReferencesRelatedInformation